Background: Hip fracture has been recognized as the most serious consequence of osteoporosis because of its complications, which include chronic pain, disability, diminished quality of life, and premature death. Osteoporotic hip fracture is an established health problem and with rising life expectancy throughout the globe, it is estimated that the incidence of hip fracture will rise from 1.66 million in 1990 to 6.26 million by 2050. Incidence of hip fracture is highest in Sweden and North America, with almost seven-fold lower rates in Southern European countries. The medical healthcare utilization associated with these high incidence rates is substantial.
Aims: To develop a protocol for international comparison of the treatment of patients with hip fracture, to perform the comparison, and to describe and explore reasons for differences in performance.
Data: In the work package micro data from hospital discharge registers, mortality registers and other relevant available national registers are being used.
Output: Country and regional-level benchmarking indicators on content of care (use of services and procedures, costs, treatment practices, process indicators) and outcome indicators. Reports and scientific articles describing the protocols, methods, indicators as well as variations between and within European countries, exploring the reasons behind the performance differences between countries, regions and providers, and evaluating the relationship between outcomes and costs.
Indicators of treatment and outcomes in the care of AMI, stroke and hip fracture:
► Medin E, Goude F, Melberg H, Tediosi F, Belicza É, Peltola M. 2015. European regional differences in all-cause mortality and length of stay for hip fracture patients. Health Economics 24 (Suppl. 1): 53-64.
► Häkkinen U, Rosenqvist G, Iversen T, Rehnberg C, Seppälä TT. 2015. Outcome, use of resources and their relationship in the treatment of AMI, stroke and hip fracture at European hospitals. Health Economics 24 (Suppl. 2): 116-139.
[Dec. 4th 2015]
